Silverarc Capital Management’s Gilead Sciences GILD Stock Holding History

Silverarc Capital Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-62,029	Closed	-$6.95M	–	72
2025 Q1	$6.95M	Buy	62,029 +52,029	+520%	+$5.37M	1.42%	23
2024 Q4	$924K	Buy	+10,000	New	+$900K	0.2%	53
2023 Q4	–	Sell	-62,789	Closed	-$4.71M	–	77
2023 Q3	$4.71M	Buy	62,789 +2,341	+4%	+$180K	1.43%	32
2023 Q2	$4.66M	Buy	60,448 +318	+0.5%	+$25.4K	1.44%	24
2023 Q1	$4.99M	Buy	60,130 +8,168	+16%	+$677K	2.06%	19
2022 Q4	$4.46M	Buy	+51,962	New	+$4.11M	1.28%	31

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Silverarc Capital Management's GILD Position: Q2 2025 in Review

Silverarc Capital Management sold out of Gilead Sciences (GILD) in Q2 2025, closing a stake of 62,029 shares — an estimated $6.95M sold.

Silverarc Capital Management first reported a position in GILD in Q4 2022 and held it in 6 quarters. The position peaked at $6.95M in Q1 2025. 2,026 funds tracked by Wall St. Rank hold GILD as of Q2 2025.

Silverarc Capital Management reported no remaining Gilead Sciences position as of Q2 2025 after selling out during the quarter.
Silverarc Capital Management sold 62,029 Gilead Sciences shares in Q2 2025, an estimated $6.95M.
Silverarc Capital Management first reported a position in Gilead Sciences in Q4 2022 and held it in 6 quarters.
Silverarc Capital Management's Gilead Sciences position peaked at $6.95M in Q1 2025.
2,026 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2025.

Based on Silverarc Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.